Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABBV AbbVie	$207.65 +0.0%	$193.17	$163.81 ▼ $218.66	$366.82B	0.5	6.61 million shs	1.03 million shs
BRK.B Berkshire Hathaway	$488.12 +0.4%	$478.85	$437.90 ▼ $542.07	$1.05T	0.81	4.84 million shs	1.35 million shs
IYH iShares U.S. Healthcare ETF	$57.68 +0.5%	$56.29	$53.35 ▼ $66.59	$2.87B	0.71	450,298 shs	390,414 shs
JNJ Johnson & Johnson	$176.50 -1.1%	$163.95	$140.68 ▼ $181.16	$425.07B	0.41	8.99 million shs	2.15 million shs
LLY Eli Lilly and Company	$726.88 +4.5%	$752.46	$623.78 ▼ $972.48	$687.96B	0.44	4.17 million shs	4.39 million shs
MRK Merck & Co., Inc.	$85.10 -0.2%	$81.73	$73.31 ▼ $120.30	$212.57B	0.38	15.28 million shs	3.40 million shs
PLTR Palantir Technologies	$160.34 +2.0%	$153.92	$29.31 ▼ $190.00	$379.89B	2.6	91.92 million shs	54.85 million shs
UNH UnitedHealth Group	$307.73 +0.9%	$288.34	$234.60 ▼ $630.73	$278.70B	0.43	12.80 million shs	4.73 million shs

5G Stocks: The Path Forward is Profitable

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABBV AbbVie	-1.29%	+0.65%	+9.13%	+11.89%	+5.08%
BRK.B Berkshire Hathaway	-0.45%	+1.60%	+0.42%	-4.44%	+7.23%
IYH iShares U.S. Healthcare ETF	-1.46%	+0.17%	+0.03%	+3.76%	-12.66%
JNJ Johnson & Johnson	-0.32%	+1.29%	+6.08%	+16.50%	+8.77%
LLY Eli Lilly and Company	-2.06%	-0.40%	-14.25%	-3.95%	-26.94%
MRK Merck & Co., Inc.	-2.01%	+1.45%	+0.72%	+10.23%	-26.73%
PLTR Palantir Technologies	-0.99%	-9.69%	-1.03%	+27.38%	+394.56%
UNH UnitedHealth Group	-0.60%	-1.16%	+8.75%	+3.48%	-47.78%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABBV AbbVie	4.7474 of 5 stars	2.5	4.0	3.3	3.9	3.9	2.5	1.3
BRK.B Berkshire Hathaway	1.7534 of 5 stars	2.5	0.0	0.0	0.0	1.9	0.8	1.9
IYH iShares U.S. Healthcare ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	4.8718 of 5 stars	2.3	5.0	4.2	3.9	4.1	1.7	1.9
LLY Eli Lilly and Company	4.9992 of 5 stars	4.3	5.0	3.3	4.0	3.3	3.3	2.5
MRK Merck & Co., Inc.	4.997 of 5 stars	3.2	5.0	5.0	4.2	3.0	1.7	3.8
PLTR Palantir Technologies	1.9887 of 5 stars	2.0	3.0	0.0	0.0	3.1	1.7	1.3
UNH UnitedHealth Group	4.9638 of 5 stars	3.3	3.0	4.2	4.0	3.9	2.5	2.5

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABBV AbbVie	2.96	Moderate Buy	$214.95	3.46% Upside
BRK.B Berkshire Hathaway	3.00	Buy	$575.00	18.36% Upside
IYH iShares U.S. Healthcare ETF	2.68	Moderate Buy	$57.38	-0.34% Downside
JNJ Johnson & Johnson	2.65	Moderate Buy	$176.29	-0.18% Downside
LLY Eli Lilly and Company	2.65	Moderate Buy	$950.17	32.25% Upside
MRK Merck & Co., Inc.	2.35	Hold	$107.44	25.92% Upside
PLTR Palantir Technologies	2.09	Hold	$136.61	-12.40% Downside
UNH UnitedHealth Group	2.50	Moderate Buy	$365.38	19.62% Upside

Current Analyst Ratings Breakdown

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/21/2025	JNJ Johnson & Johnson	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$185.00 ➝ $200.00
8/20/2025	UNH UnitedHealth Group	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$342.00 ➝ $325.00
8/18/2025	UNH UnitedHealth Group	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$290.00 ➝ $325.00
8/17/2025	LLY Eli Lilly and Company	Daiwa Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$700.00
8/17/2025	LLY Eli Lilly and Company	Daiwa America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
8/14/2025	LLY Eli Lilly and Company	DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/13/2025	LLY Eli Lilly and Company	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$975.00 ➝ $825.00
8/13/2025	LLY Eli Lilly and Company	Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$942.00 ➝ $875.00
8/12/2025	ABBV AbbVie	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$231.00
8/11/2025	ABBV AbbVie	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/11/2025	LLY Eli Lilly and Company	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$1,010.00 ➝ $900.00

(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABBV AbbVie	$56.33B	6.52	$14.73 per share	14.10	$1.90 per share	109.35
BRK.B Berkshire Hathaway	$397.15B	2.64	$27.78 per share	17.49	$302.19 per share	1.61
IYH iShares U.S. Healthcare ETF	N/A	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$88.82B	4.79	$12.93 per share	13.66	$29.69 per share	5.95
LLY Eli Lilly and Company	$45.04B	15.10	$14.37 per share	50.00	$15.03 per share	47.80
MRK Merck & Co., Inc.	$64.17B	3.32	$9.24 per share	9.23	$18.33 per share	4.65
PLTR Palantir Technologies	$3.44B	107.53	$0.09 per share	1,720.57	$2.18 per share	71.54
UNH UnitedHealth Group	$400.28B	0.69	$32.19 per share	9.49	$106.78 per share	2.86

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABBV AbbVie	$4.28B	$2.10	98.87	14.86	1.35	6.45%	699.66%	13.64%	10/29/2025 (Estimated)
BRK.B Berkshire Hathaway	$89.00B	$29.17	16.64	24.36	3.39	17.00%	6.96%	3.92%	N/A
IYH iShares U.S. Healthcare ETF	N/A	N/A	21.05	∞	N/A	N/A	N/A	N/A	N/A
JNJ Johnson & Johnson	$14.07B	$9.35	18.93	15.95	2.28	25.00%	32.49%	13.00%	10/21/2025 (Estimated)
LLY Eli Lilly and Company	$10.59B	$15.30	46.95	23.09	0.99	25.91%	92.72%	16.89%	10/29/2025 (Estimated)
MRK Merck & Co., Inc.	$17.12B	$6.49	13.15	8.62	0.92	25.79%	41.05%	16.55%	10/30/2025 (Estimated)
PLTR Palantir Technologies	$462.19M	$0.30	515.89	458.69	8.95	22.18%	10.75%	8.71%	11/3/2025 (Estimated)
UNH UnitedHealth Group	$14.41B	$23.08	13.27	9.19	1.98	5.04%	23.32%	7.66%	10/21/2025 (Estimated)

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	LLY Eli Lilly and Company	$5.59	$6.31	+$0.72	$6.29	$14.40 billion	$15.56 billion
8/4/2025	Q2 2025	PLTR Palantir Technologies	$0.14	$0.16	+$0.02	$0.13	$939.29 million	$1.00 billion
7/31/2025	Q2 2025	ABBV AbbVie	$3.24	$2.97	-$0.27	$0.52	$14.93 billion	$15.42 billion
7/29/2025	Q2 2025	MRK Merck & Co., Inc.	$2.03	$2.13	+$0.10	$1.76	$15.92 billion	$15.81 billion
7/29/2025	Q2 2025	UNH UnitedHealth Group	$4.45	$4.08	-$0.37	$3.74	$111.75 billion	$111.62 billion
7/16/2025	Q2 2025	JNJ Johnson & Johnson	$2.68	$2.77	+$0.09	$2.29	$22.85 billion	$23.74 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABBV AbbVie	$6.56	3.16%	N/A	312.38%	53 Years
BRK.B Berkshire Hathaway	N/A	N/A	N/A	N/A	N/A
IYH iShares U.S. Healthcare ETF	$0.76	1.32%	N/A	N/A	N/A
JNJ Johnson & Johnson	$5.20	2.94%	N/A	55.61%	64 Years
LLY Eli Lilly and Company	$6.00	0.84%	N/A	39.22%	11 Years
MRK Merck & Co., Inc.	$3.24	3.80%	N/A	49.92%	14 Years
PLTR Palantir Technologies	N/A	N/A	N/A	N/A	N/A
UNH UnitedHealth Group	$8.84	2.89%	N/A	38.30%	15 Years

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/22/2025	MRK Merck & Co., Inc.	quarterly	$0.81	3.97%	9/15/2025	9/15/2025	10/7/2025
8/13/2025	UNH UnitedHealth Group	quarterly	$2.21	3.38%	9/15/2025	9/15/2025	9/23/2025
6/23/2025	LLY Eli Lilly and Company	quarterly	$1.50	0.78%	8/15/2025	8/15/2025	9/10/2025
7/16/2025	JNJ Johnson & Johnson	quarterly	$1.30	3.35%	8/26/2025	8/26/2025	9/9/2025
6/20/2025	ABBV AbbVie	quarterly	$1.64	3.54%	7/15/2025	7/15/2025	8/15/2025
5/27/2025	MRK Merck & Co., Inc.	quarterly	$0.81	4.18%	6/16/2025	6/16/2025	7/8/2025
6/5/2025	UNH UnitedHealth Group	quarterly	$2.21	3%	6/16/2025	6/16/2025	6/24/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABBV AbbVie	44.14	0.74	0.61
BRK.B Berkshire Hathaway	N/A	0.47	0.47
IYH iShares U.S. Healthcare ETF	N/A	N/A	N/A
JNJ Johnson & Johnson	0.50	1.01	0.76
LLY Eli Lilly and Company	1.86	1.28	1.00
MRK Merck & Co., Inc.	0.69	1.42	1.17
PLTR Palantir Technologies	N/A	6.32	6.32
UNH UnitedHealth Group	0.73	0.85	0.85

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABBV AbbVie	70.23%
BRK.B Berkshire Hathaway	39.25%
IYH iShares U.S. Healthcare ETF	N/A
JNJ Johnson & Johnson	69.55%
LLY Eli Lilly and Company	82.53%
MRK Merck & Co., Inc.	76.07%
PLTR Palantir Technologies	45.65%
UNH UnitedHealth Group	87.86%

Insider Ownership

Company	Insider Ownership
ABBV AbbVie	0.08%
BRK.B Berkshire Hathaway	6.05%
IYH iShares U.S. Healthcare ETF	N/A
JNJ Johnson & Johnson	0.16%
LLY Eli Lilly and Company	0.14%
MRK Merck & Co., Inc.	0.09%
PLTR Palantir Technologies	9.23%
UNH UnitedHealth Group	0.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABBV AbbVie	55,000	1.77 billion	1.77 billion	Optionable
BRK.B Berkshire Hathaway	392,400	2.16 billion	2.03 billion	Optionable
IYH iShares U.S. Healthcare ETF	N/A	49.75 million	N/A	Not Optionable
JNJ Johnson & Johnson	138,100	2.41 billion	2.40 billion	Optionable
LLY Eli Lilly and Company	47,000	946.46 million	945.13 million	Optionable
MRK Merck & Co., Inc.	75,000	2.50 billion	2.50 billion	Optionable
PLTR Palantir Technologies	3,936	2.37 billion	2.07 billion	Optionable
UNH UnitedHealth Group	400,000	905.67 million	903.14 million	Optionable

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Headlines

Recent News About These Companies

UnitedHealth's Misdiagnosis: Can Berkshire's Bet Spark a Recovery?

3 hours ago | zacks.com

As the Market Rotates, This Healthcare ETF Is Leading the Way (UNH)

...

5 hours ago | marketbeat.com

UnitedHealth Group Incorporated $UNH Shares Acquired by Caisse DE Depot ET Placement DU Quebec

August 26 at 8:46 AM | marketbeat.com

Corebridge Financial Inc. Sells 6,253 Shares of UnitedHealth Group Incorporated $UNH

August 26 at 8:38 AM | marketbeat.com

UnitedHealth Group Incorporated $UNH Stock Holdings Lessened by Kayne Anderson Rudnick Investment Management LLC

August 26 at 7:41 AM | marketbeat.com

Zacks Research Analysts Boost Earnings Estimates for UNH

August 26 at 2:51 AM | americanbankingnews.com

Is UnitedHealth’s (UNH) Capital Strategy Signaling Strength or Defensive Caution in a Shifting Sector?

August 25 at 4:04 PM | finance.yahoo.com

Promising Medical Stocks To Watch Today - August 24th

August 25 at 2:03 PM | marketbeat.com

UnitedHealth Invests in Behavioral Health: A Bet on Future Demand?

August 25 at 1:16 PM | zacks.com

Top Financial Stocks To Watch Today - August 24th

August 25 at 12:06 PM | marketbeat.com

Top 5 ETFs and Stocks to Watch as the Fed Eyes Rate Cuts (UNH)

...

August 25 at 11:05 AM | marketbeat.com

UnitedHealth: UNH Stock To $600?

August 25 at 11:03 AM | forbes.com

Thematics Asset Management Grows Position in UnitedHealth Group Incorporated $UNH

August 25 at 8:30 AM | marketbeat.com

Ally Financial Inc. Buys 7,000 Shares of UnitedHealth Group Incorporated $UNH

August 25 at 8:30 AM | marketbeat.com

53 House LLP Has $45.23 Million Position in UnitedHealth Group Incorporated $UNH

August 25 at 8:30 AM | marketbeat.com

UnitedHealth Group Incorporated $UNH Shares Sold by Comerica Bank

August 25 at 8:10 AM | marketbeat.com

MetLife Investment Management LLC Sells 4,588 Shares of UnitedHealth Group Incorporated $UNH

August 25 at 7:47 AM | marketbeat.com

Synovus Financial Corp Has $21.65 Million Stock Position in UnitedHealth Group Incorporated $UNH

August 25 at 7:39 AM | marketbeat.com

Campbell & CO Investment Adviser LLC Takes $4.07 Million Position in UnitedHealth Group Incorporated $UNH

August 25 at 7:23 AM | marketbeat.com

Quantitative Investment Management LLC Buys New Position in UnitedHealth Group Incorporated $UNH

August 25 at 7:07 AM | marketbeat.com

AlphaQuest LLC Acquires 1,608 Shares of UnitedHealth Group Incorporated $UNH

August 25 at 5:31 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Company Descriptions

AbbVie NYSE:ABBV

$207.65 +0.10 (+0.05%)

As of 02:16 PM Eastern

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Berkshire Hathaway NYSE:BRK.B

$488.12 +1.94 (+0.40%)

As of 02:16 PM Eastern

Berkshire Hathaway Inc., through its subsidiaries, engages in the insurance, freight rail transportation, and utility businesses worldwide. The company provides property, casualty, life, accident, and health insurance and reinsurance; and operates railroad systems in North America. It also generates, transmits, stores, and distributes electricity from natural gas, coal, wind, solar, hydroelectric, nuclear, and geothermal sources; operates natural gas distribution and storage facilities, interstate pipelines, liquefied natural gas facilities, and compressor and meter stations; and holds interest in coal mining assets. In addition, the company manufactures boxed chocolates and other confectionery products; specialty chemicals, metal cutting tools, and components for aerospace and power generation applications; flooring products; insulation, roofing, and engineered products; building and engineered components; paints and coatings; and bricks and masonry products, as well as offers manufactured and site-built home construction, and related lending and financial services. Further, it provides recreational vehicles, apparel and footwear products, jewelry, and custom picture framing products, as well as alkaline batteries; castings, forgings, fasteners/fastener systems, aerostructures, and precision components; and cobalt, nickel, and titanium alloys. Additionally, the company distributes televisions and information; franchises and services quick service restaurants; distributes electronic components; and offers logistics services, grocery and foodservice distribution services, and professional aviation training and shared aircraft ownership programs. It also retails automobiles; furniture, bedding, and accessories; household appliances, electronics, and computers; jewelry, watches, crystal, china, stemware, flatware, gifts, and collectibles; kitchenware; and motorcycle clothing and equipment. The company was incorporated in 1998 and is headquartered in Omaha, Nebraska.

iShares U.S. Healthcare ETF NYSEARCA:IYH

$57.68 +0.30 (+0.52%)

As of 02:15 PM Eastern

iShares U.S. Healthcare ETF (the Fund), formerly iShares Dow Jones U.S. Healthcare Sector Index Fund (the Fund) is a non-diversified exchange-traded fund. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Dow Jones U.S. Health Care Index (the Index). The Index measures the performance of the healthcare sector of the United States equity market, and includes companies in the industry groups, such as healthcare equipment and services, pharmaceuticals and biotechnology. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund's investment advisor is BlackRock Fund Advisors (BFA).

Johnson & Johnson NYSE:JNJ

$176.50 -1.91 (-1.07%)

As of 02:16 PM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Eli Lilly and Company NYSE:LLY

$726.88 +31.55 (+4.54%)

As of 02:16 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Merck & Co., Inc. NYSE:MRK

$85.10 -0.21 (-0.24%)

As of 02:16 PM Eastern

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Palantir Technologies NASDAQ:PLTR

$160.34 +3.17 (+2.02%)

As of 02:16 PM Eastern

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates under the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

UnitedHealth Group NYSE:UNH

$307.73 +2.87 (+0.94%)

As of 02:16 PM Eastern

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Earnings

Compare Dividends

Latest IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

IYH, PLTR, JNJ, ABBV, LLY, UNH, MRK, and BRK.B Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools